Drug Shortage Report for PMS-URSODIOL C
Report ID | 244166 |
Drug Identification Number | 02273500 |
Brand name | PMS-URSODIOL C |
Common or Proper name | URSODIOL |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | URSODIOL |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A05AA |
ATC description | BILE THERAPY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-11-28 |
Estimated end date | 2024-12-20 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-11-29 | French | Compare |
v1 | 2024-11-29 | English | Compare |
Showing 1 to 2 of 2